Circulation-Enhancing Device Improves CPR by unknown
 Health and Medicine  Spinoff 2007
Originating	Technology/NASA	Contribution
Ever	 stand	 up	 too	 quickly	 from	 a	 sitting	 or	lying	 position	 and	 feel	 dizzy	 or	 disoriented	for	 a	 brief	moment?	The	 downward	 push	 of	
Earth’s	gravity	naturally	causes	blood	to	settle	in	the	


















sional	 fainting,	blurry	 vision,	 and	pain	or	discomfort	
in	 the	head	and	the	neck,	 to	 tiredness,	weakness,	and	
a	lack	of	concentration.	Though	research	indicates	that	
the	 condition	 is	 not	 life-threatening,	 it	 could	 impact	
the	quality	of	life	and	contribute	to	falls	that	result	in	seri-
ous	injuries.
The	 condition	 is	 a	 prominent	 concern	 for	NASA,	
since	 astronauts	 have	 to	 readjust	 to	 the	 gravitational	











Cardiovascular	 experts	 at	 NASA	 have	 found	 that	
the	 blood	 that	 normally	 settles	 in	 the	 lower	 regions	
of	the	body	is	instead	pulled	to	the	upper	body	in	the	
microgravity	 environment	 of	 space.	 Blood	 volume	 is	
subsequently	 reduced	 as	 some	 cardiovascular	 reflexes	















NASA	 has	 conducted	 and	 sponsored	 a	 wealth	 of	
studies	to	counter	the	effects	of	orthostatic	intolerance,	
especially	since	the	condition	could	prevent	an	astronaut	














in	 the	body.	A	 separate	Ames	 study	 is	 evaluating	 the	
possibility	 of	 expanding	 astronauts’	 plasma	 volumes	
(the	fluid	part	of	the	blood,	minus	the	blood	cells),	as	a	
preventative	measure.	
Circulation-Enhancing Device Improves CPR
The ResQPOD is an impedance threshold device used to 
enhance circulation during CPR. It could be used to increase 
circulation for astronauts as their bodies initially adjust to a 
return to gravity from the weightlessness of space.
https://ntrs.nasa.gov/search.jsp?R=20080003935 2019-08-30T02:07:06+00:00Z
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In	NASA-sponsored	research	at	Vanderbilt	University,	
researchers	have	successfully	identified	a	genetic	cause	for	



























research	 effort,	 including	 six	 published	 studies.	 The	
published	works	demonstrate	 that	ResQPOD	offers	a	





role	 in	 the	 company	 obtaining	U.S.	 Food	 and	Drug	
Administration	501K	clearance	for	the	device.
The ResQPOD increases circulation in states of low blood pressure. When used on patients in cardiac arrest, the ResQPOD 
harnesses the chest wall recoil after each compression to generate a small but critical vacuum within the chest. This vacuum 
enhances blood flow back to the heart and results in a marked increase in blood flow out of the heart with each subsequent 
chest compression.
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The ResQPOD 
doubles blood flow 
back to the heart. 
CPR delivers 
approximately 1 
percent of normal blood 
flow to the heart.
During the decompression (release) phase of 
CPR, an increase in negative pressure in the 
thoracic cavity results in drawing more blood 
back into the chest, providing greater venous 









for	NASA’s	 space	 shuttle	missions,	 added	ResQPOD	
to	 the	 list	 of	medical	 equipment	 that	 is	 available	 for	
returning	astronaut	crews.	The	device	was	on	hand	for	
the	 landing	 of	 Space	 Shuttle	 Atlantis	 (STS-115)	 on	
September	21,	2006.	
“We’re	 excited	 that	 our	 devices	were	 available	 to	
the	medical	team	[for	the	STS-115	mission]	and	look	
forward	to	continued	collaboration	with	NASA	to	assist	































by	 temporarily	 sealing	off	 the	airway	between	breaths	
and	preventing	unnecessary	air	from	entering	the	chest	
























brain	 is	 increased	by	50	percent.	 In	sustaining	proper	




























percent of normal 
blood flow to the brain.
The ResQPOD delivers 
more than 0 percent 
of normal blood flow to 
the brain.
Improved venous return results in increased 
cardiac output during the subsequent 
compression phase of CPR, providing greater 
blood flow to the brain.
